FT商学院

Moderna is most shorted stock in S&P 500 as Americans skip jabs

Maker of Covid-19 shots has slumped since pandemic as people turn against vaccines

Vaccine-maker Moderna has become the most shorted company in the S&P 500, with its share price slumping to its lowest level since before the Covid-19 pandemic as people skip jabs.

After months of anti-vax rhetoric from US health secretary Robert F Kennedy Jr, the number of Americans getting Covid shots is down about 24 per cent from this point last year, according to a November 21 report from Jefferies, an investment bank.

Despite plenty of supply, analysts have said vaccine fatigue was contributing to lower Covid vaccination rates in the past few months compared with 2024 or 2023.

您已阅读13%(586字),剩余87%(3802字)包含更多重要信息,订阅以继续探索完整内容,并享受更多专属服务。
版权声明:本文版权归manbetx20客户端下载 所有,未经允许任何单位或个人不得转载,复制或以任何其他方式使用本文全部或部分,侵权必究。
设置字号×
最小
较小
默认
较大
最大
分享×